Abstract:In the recent era, scientific interest has been piqued by Helicobacter pylori , a bacterium that resides in the human stomach and has been linked to a range of gastrointestinal disorders including gastritis, peptic ulcers, and an increased risk of gastric cancer. In this study, we conducted synthesis, characterization, DFT-based investigations, and in silico biological assessments of three novel dipeptide-sulphonamide derivatives to evaluate their potential as drug candidates targeting H. pylori receptors. The results of the vibrational energy distribution study were compared to the experimental vibrational frequencies, and they were found to be in good agreement. Investigation of intramolecular charge transfer interactions and stabilization energies was conducted through natural bond orbital (NBO) analysis. The analysis revealed a range of stabilization energies, with compound C exhibiting the highest energy of 657.15 kcal/mol, followed by compound A at 448.97 kcal/mol, and compound B at 418.97 kcal/mol. This order of stability correlates with their reactivity, as evidenced by energy values of 7.6693 eV for compound C, 8.4154 eV for compound A, and 8.9295 eV for compound B. These findings suggest that compound C is the most reactive among the studied species. The molecular docking results revealed that the ligands; N -(2-(Isobutylamino)-2-oxoethyl)-3-methyl-2-(4-methylphenylsulphonamido) pentanamide (A ), N -(2-(Isobutylamino)-2-oxoethyl)-3-methyl-2-(phenylsulphonamido) pentanamide (B), and N- (2(Isobutylamino)2-oxoethyl)3-methyl-2(4-nitrophenylsulphonamido) pentanamide (C) exhibited excellent selectivity and reactivity with the protein 2QV3 compared to the standard lansoprazole. The findings clearly show that these novel dipeptide-sulphonamides could represent a new class of potential anti-ulcer agents and, with further research, could be used as new anti-ulcer medications.

Metronidazole–Deoxybenzoin Derivatives As Anti‐Helicobacter Pylori Agents with Potent Inhibitory Activity Against HPE‐Induced Interleukin‐8

Metronidazole-flavonoid derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8 production by AGS cells.

Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.

Three flavonoids targeting the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: Crystal structure characterization with enzymatic inhibition assay

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

The synthesis, structure and activity evaluation of secnidazole derivatives as helicobacter pylori urease inhibitors

Discovery of Cinnamic Acid Derivatives as Potent Anti-H. pylori Agents

Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors.

Developing potential Helicobacter pylori urease inhibitors from novel oxoindoline derivatives: Synthesis, biological evaluation and in silico study.

Synthesis, Molecular Docking and Kinetic Properties of Β-Hydroxy-β-phenylpropionyl-hydroxamic Acids As Helicobacter Pylori Urease Inhibitors

The Synthesis, Structure and Activity Evaluation of Pyrogallol and Catechol Derivatives As Helicobacter Pylori Urease Inhibitors

Synthesis, characterization, DFT studies, and in silico biological evaluation of novel dipeptide-sulphonamide derivatives against Helicobacter pylori receptors

Discovery and evolution of berberine analogues as anti-Helicobacter pylori agents with multi-target mechanisms

Synthesis, molecular docking and biological evaluation of 3-arylfuran-2(5H)-ones as anti-gastric ulcer agent

Antibacterial and antibiofilm agents in the group of xanthone derivatives with piperazine moiety active against drug-resistant Helicobacter pylori strains

Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.

Synthesis and Evaluation of N-analogs of 1,2-Diarylethane As Helicobacter Pylori Urease Inhibitors.

Arylamino Containing Hydroxamic Acids As Potent Urease Inhibitors for the Treatment of Helicobacter Pylori Infection.

Effects of Oiliness Extracts from Rose Family Plant Fruit Core Against Helicobacter Pylori in Vitro and in Vivo

Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori

The Synthesis and Evaluation of Phenoxyacylhydroxamic Acids As Potential Agents for Helicobacter Pylori Infections